Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

Bioconjugation Market Bioconjugation Market Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Bioconjugation Market by Product ...

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, ...

AbbVie Inc. (NYSE:ABBV) showed positive top-line growth from its immunosuppressive drugs, Skyrizi and Rinvoq. Abbvie’s management continues to work through the loss of exclusivity from Humira ...

FOX 8 News’ Wayne Dawson is sharing an update on his health after receiving a surprising diagnosis of oral cancer earlier ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out daily tasks such as eating and walking, months after the drugmaker ...

AbbVie, a drug company based in North Chicago, Illinois, is paying $200 million to acquire Madison-based Nimble Therapeutics, which is developing an oral therapy that could treat psoriasis and ...

Johnston also found “it makes little sense” to say the manufacturers failed to demonstrate that there are no circumstances where a law targeting drug manufacturers can be legitimately applied. “Swap ...

The revision reflects new projections for the pharmaceutical company's drugs Skyrizi and Rinvoq, which are used to treat ulcerative colitis (UC) and Crohn's disease (CD). With trailing twelve-month ...